Clinical trials
Metabolic Diseases trials in Belgium
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2009 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Recruiting | 3 |
| Active, not recruiting | 2 |
| Terminated | 2 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| 89bio, Inc. | 3 |
| Pfizer | 3 |
| Alexion Pharmaceuticals, Inc. | 1 |
| Calcilytix Therapeutics, Inc., a BridgeBio company | 1 |
| Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 1 |
| Eli Lilly and Company | 1 |
| Erasme University Hospital | 1 |
| Fractyl Health Inc. | 1 |
| Ionis Pharmaceuticals, Inc. | 1 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Metabolic Diseases | 18 |
| Lipid Metabolism Disorders | 6 |
| Hyperlipidemias | 5 |
| Diabetes Mellitus | 4 |
| Diabetes Mellitus, Type 2 | 3 |
| Dyslipidemias | 3 |
| Endocrine System Diseases | 3 |
| Glucose Metabolism Disorders | 3 |
| Non-alcoholic Fatty Liver Disease | 3 |
| Digestive System Diseases | 2 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.